|
1
|
Tambini CE, Spink KG, Ross CJ, Hill MA and
Thacker J: The importance of XRCC2 in RAD51-related DNA damage
repair. DNA Repair (Amst). 9:517–525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan C, Liu X, Yan S, Wang C and Kong B:
Analyzing association of the XRCC3 gene polymorphism with ovarian
cancer risk. Biomed Res Int. 2014:6481372014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Popanda O, Schattenberg T, Phong CT,
Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, et
al: Specific combinations of DNA repair gene variants and increased
risk for non-small cell lung cancer. Carcinogenesis. 25:2433–2441.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bănescu C, Trifa AP, Demian S, Benedek
Lazar E, Dima D, Duicu C and Dobreanu M: Polymorphism of XRCC1,
XRCC3 and XPD genes and risk of chronic myeloid leukemia. Biomed
Res Int. 2014:2137902014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park DJ, Lesueur F, Nguyen-Dumont T,
Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL,
Terry MB, et al: Rare mutations in XRCC2 increase the risk of
breast cancer. Am J Hum Genet. 90:734–739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He Y, Zhang Y, Jin C, Deng X, Wei M, Wu Q,
Yang T, Zhou Y and Wang Z: Impact of XRCC2 Arg188His polymorphism
on cancer susceptibility, A meta-analysis. PLoS One. 9:e912022014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smolarz B, Makowska M, Samulak D,
Michalska MM, Mojs E, Wilczak M and Romanowicz H: Association
between single nucleotide polymorphism (SNPs) of XRCC2 and XRCC3
homologous recombination repair genes and triple-negative breast
cancer in Polish women. Clin Exp Med. 15:151–157. 2105. View Article : Google Scholar
|
|
8
|
Romanowicz-Makowska H, Smolarz B, Gajęcka
B, Kiwerska K, Rydzanicz M, Kaczmarczyk D, Olszewski J, Szyfter K,
Błasiak J and Morawiec-Sztandera A: Polymorphism of the DNA repair
genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal
cancer in a Polish population. Arch Med Sci. 8:1065–1075. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiao L, Hassan M, Bondy ML, Wolff RA,
Evans DB, Abbruzzese JL and Li D: XRCC2 and XRCC3 gene polymorphism
and risk of pancreatic cancer. Am J Gastroenterol. 103:360–367.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brooks J, Shore RE, Zeleniuch-Jacquotte A,
Currie D, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P and Wirgin
I: Polymorphisms in RAD51, XRCC2 and XRCC3 are not related to
breast cancer risk. Cancer Epidemiol Biomarkers Prev. 17:1016–1019.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin XP, Zhou Y, Chen Y, Li NN and Wu XT:
XRCC3 Thr241Met polymorphism and gastric cancer susceptibility, A
meta-analysis. Clin Res Hepatol Gastroenterol. 38:226–234. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nissar S, Sameer AS, Lone TA, Chowdri NA
and Rasool R: XRCC3 Thr241Met gene polymorphism and risk of
colorectal cancer in kashmir, A case control study. Asian Pac J
Cancer Prev. 15:9621–9625. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Curtin K, Lin WY, George R, Katory M,
Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A and Camp
NJ: Colorectal Cancer Study Group. Genetic variants in XRCC2: New
insights into colorectal cancer tumorigenesis. Cancer Epidemiol
Biomarkers Prev. 18:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gok I, Baday M, Cetinkunar S, Kilic K and
Bilgin BC: Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk
of gastric cancer in Turkey. Bosn J Basic Med Sci. 13:214–218.
2014. View Article : Google Scholar
|
|
15
|
Benhamou S, Tuimala J, Bouchardy C, Dayer
P, Sarasin A and Hirvonen A: DNA repair gene XRCC2 and XRCC3
polymorphisms and susceptibility to cancers of the upper
aerodigestive tract. Int J Cancer. 112:901–904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhand Y, Wang H, Peng Y, Liu Y, Xiong T,
Xue P and Du L: The Arg188His polymorphism in the XRCC2 gene and
the risk of cancer. Tumour Biol. 35:3541–3549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan Y, Liang H, Li R, Xie L, Li M, Li S
and Qin X: XRCC3 Thr241Met polymorphism and ovarian cancer risk, A
meta-analysis. Tumor Biol. 35:2711–2715. 2014. View Article : Google Scholar
|
|
18
|
Fayaz S, Fard-Esfahani P, Fard-Esfahani A,
Mostafavi E, Meshkani R, Mirmiranpour H and Khaghani S: Assessment
of genetic mutations in the XRCC2 coding region by high resolution
melting curve analysis and the risk of differentiated thyroid
carcinoma in Iran. Genet Mol Biol. 35:32–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan Y, Liang H, Li T, Guo S, Li M, Qin X
and Li S: Association of XRCC3 Thr241Met polymorphism and leukemia
risk, Evidence from a meta-analysis. Leuk Lymphoma. 55:2130–2134.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duell EJ, Bracci PM, Moore JH, Burk RD,
Kelsey KT and Holly EA: Detecting pathway-based gene-gene and
gene-environment interactions in pancreatic cancer. Cancer
Epidemiol Biomarkers Prev. 17:1470–1479. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li D, Liu H, Jiao L, Chang DZ, Beinart G,
Wolff RA, Evans DB, Hassan MM and Abbruzzese JL: Significant effect
of homologous recombination DNA repair gene polymorphisms on
pancreatic cancer survival. Cancer Res. 66:3323–3330. 2006.
View Article : Google Scholar : PubMed/NCBI
|
